Toth Financial Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Toth Financial Advisory's MRNA Position: Q3 2026 in Review
Toth Financial Advisory increased its Moderna (MRNA) stake by 30% in Q3 2026, buying an estimated $72.6K and bringing the position to 2,934 shares worth $565K. The position accounts for 0.06% of the portfolio, ranked #167.
Toth Financial Advisory first reported a position in MRNA in Q2 2020 and has held it in 26 quarters since. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Toth Financial Advisory held 2,934 shares of Moderna worth $565K as of Q3 2026.
- Toth Financial Advisory bought 674 Moderna shares in Q3 2026, an estimated $72.6K.
- Moderna made up 0.06% of Toth Financial Advisory's portfolio in Q3 2026, its #167 holding.
- Toth Financial Advisory first reported a position in Moderna in Q2 2020 and has held it in 26 quarters since.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.